Myeloma therapy: pursuing the plasma cell

por Cavenagh, J
Publicado 2010

Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia

por Dalley, C D, Lister, T A, Cavenagh, J D, Rohatiner, A Z S
Publicado 2001

Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib

por Ishii, T, Seike, T, Nakashima, T, Juliger, S, Maharaj, L, Soga, S, Akinaga, S, Cavenagh, J, Joel, S, Shiotsu, Y
Publicado 2012

Mullins’ syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra

por Longhurst, H.J., Yong, P.F.K., Manson, A.L., Cavenagh, J.D., Grigoriadou, S., Buckland, M.S.
Publicado 2015

Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies

por Yong, K, Cavet, J, Johnson, P, Morgan, G, Williams, C, Nakashima, D, Akinaga, S, Oakervee, H, Cavenagh, J
Publicado 2016

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities()

por Dennis, M., Culligan, D., Karamitros, D., Vyas, P., Johnson, P., Russell, N.H., Cavenagh, J., Szubert, A., Hartley, S., Brown, J., Bowen, D.
Publicado 2013

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

por Cavenagh, J, Oakervee, H, Baetiong-Caguioa, P, Davies, F, Gharibo, M, Rabin, N, Kurman, M, Novak, B, Shiraishi, N, Nakashima, D, Akinaga, S, Yong, K
Publicado 2017

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

por Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Illes, A, Fenaux, P, DeAngelo, D J, Stauder, R, Yee, K, Zhu, N, Lee, J-H, Valcarcel, D, MacWhannell, A, Borbenyi, Z, Gazi, L, Acharyya, S, Ide, S, Marker, M, Ottmann, O G
Publicado 2017

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence

por Heydt, Q., Xintaropoulou, C., Clear, A., Austin, M., Pislariu, I., Miraki-Moud, F., Cutillas, P., Korfi, K., Calaminici, M., Cawthorn, W., Suchacki, K., Nagano, A., Gribben, J. G., Smith, M., Cavenagh, J. D., Oakervee, H., Castleton, A., Taussig, D., Peck, B., Wilczynska, A., McNaughton, L., Bonnet, D., Mardakheh, F., Patel, B.
Publicado 2021